The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, ...

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

Nasal spray tech facilitates the delivery of proteins, small-molecule drugs and peptides. Credit: 1777177/Shutterstock. The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal ...

Rebound congestion can happen when decongestant nasal sprays are used for longer than seven days. Prolonged use irritates the inside of the nose ... my mouth’s dry, and eating is hard as ...

A WOMAN had to miss her brother’s wedding due to suffering from extreme hay fever, which left her eyes ‘red raw’. Jasmine ...

But don't sniff it. You want it to stay in the nose". Nicola concluded her video by assuring viewers that this technique would "change your life" when it comes to using nasal spray.

ITCHY eyes, constant sneezing, a runny nose… all signs hay fever season is well and truly here. Yep, that joyous time of the year when one in four Brits dreads the smell of freshly-cut grass ...

plan to use the grant funding to adapt the nasal spray technology they originally developed for COVID-19 and human influenza. The vaccine could also potentially be used in humans, if necessary ...

That's when a rhinologist on the team mentioned nasal application. "He told us, 'You can put anything in the nose,'" Mulligan said. Oral supplements don't work for several reasons. A specific ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Nagpur: Researchers from Nagpur University's postgraduate department of pharmaceutical sciences have developed a new treatment method for the direct delivery of drugs through the nose to target ...

Zavegepant 10 mg nasal spray provided rapid and safe relief from acute migraine attacks but did not exhibit long-term superiority over oral calcitonin gene-related peptide receptor antagonists.